Isabella Houweling-Gazzoli, PhD
Dr. Isabella Houweling-Gazzoli is a postdoc researcher in the DMD Genetic Therapy Group since October 2009. She is currently involved in the transcriptome analysis of the DMD gene and in exploring AON-mediated exon skipping as a potential therapeutic approach for Dysferlinopathies. She previously worked for two different biotechnology companies (DSM Anti-Infectives, Delft and Genmab BV, Molecular Biology Unit, Utrecht). She also performed research at Ludwig Institute for Cancer Research, UCSD, La Jolla, CA, USA and received her Ph.D. degree in Molecular Genetics, Utrecht University (Promotors: Prof. Dr. Hans Clevers and Prof. Dr. Richard Kolodner).